Oncosis Photosis Cellular Therapy One-Year Trial To Commence By Year-End
This article was originally published in The Gray Sheet
Executive Summary
Cellular therapy start-up Oncosis, Inc. is projecting a U.S. market launch of its Photosis platform technology for non-Hodgkin's lymphoma by 2005, contingent on PMA approval